9 results
pharmacology treatment hivaids infections opportunistic coccidioidomycosis mycobacterium agents agitation antibiogram antifungals aviumcomplex bacterial candida candidiasis cmv comparison coverage criticalcare cytomegalovirus
Spectrum of activity for systemic antifungal agents Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... itraconazole; MICA ... dermatitidis, Coccidioides ... #antibiogram #management ... #pharmacology #
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... mg IV) q12h if MIC ... Enteric #Bacterial #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... Note: Systemic antifungals ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Pain, Agitation, and Delirium (PAD) in the ICU Addressing the ICU Triad (PAD) can be accomplished through
A dissociative drug ... No pharmacologic ... be effective in preventing ... be effective in preventing ... CriticalCare #diagnosis #management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis. Fluconazole - Low
tolerable • High MIC ... • Therapeutic drug ... Coccidioidomycosis #coccidioides ... #valleyfever #management ... comparison #table #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS Preventing 1st Episode of Disseminated
IDSA Recommendations ... for Preventing ... AviumComplex #MAC #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis Fluconazole - Benefits: Low cost/tolerable
Weaknesses: High MIC ... Weaknesses: Therapeutic drug ... Coccidioidomycosis #pharmacology ... #management #treatment ... #coccidioides
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
IDSA Recommendations ... intraocular levels of drug ... Cytomegalovirus #CMV #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
IDSA Recommendations ... Tuberculosis #TB #IDSA ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
No results found for "MICU+pharmacology+drugs anatomy management antifungal prevention idsa coccidioides"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MICU+pharmacology+drugs #anatomy #management #antifungal #prevention #idsa #coccidioides